Submucosal Hyper-Echogenicity Predicts Treatment Non-Response in Ulcerative Colitis

Overview

This study demonstrates that submucosal hyper-echogenicity detected by intestinal ultrasound (IUS) in ulcerative colitis (UC) patients corresponds to fat deposition in the bowel wall and predicts a lack of response to anti-inflammatory treatment. Quantitative measurement of relative submucosal echogenicity (RSE) was significantly higher in non-responders compared to responders, providing a potential imaging biomarker for treatment outcomes.

Background

Ulcerative colitis is traditionally considered a mucosal disease, but recent evidence indicates transmural changes including submucosal fat and collagen deposition. Intestinal ultrasound is a non-invasive imaging modality that can assess bowel wall layers and inflammation. The submucosal layer is notably thickened and hyper-echogenic in some UC patients, but the histopathological correlates and clinical implications of this finding have not been fully elucidated. This study aimed to quantify submucosal echogenicity and evaluate its relationship with histopathology and treatment response.

Data Highlights

Key Findings

• Submucosal hyper-echogenicity on IUS correlates strongly with fat deposition in the submucosal layer of UC patients.
• UC patients with preserved bowel wall stratification showed submucosal fat in 63% of cases; those with loss of stratification lacked fat deposition.
• Relative submucosal echogenicity (RSE) was significantly higher in patients with submucosal fat compared to those without (median 95.5 vs 8.1 grayscale values, P < .001).
• In a prospective cohort, baseline RSE was significantly higher in patients who did not respond to anti-inflammatory treatment compared to responders (137.1 vs 88.3 grayscale values, P = .003).
• An RSE threshold of greater than 108 grayscale values predicted non-response with an odds ratio of 0.07 (95% CI: 0.01–0.44, P = .004).
• No significant differences in submucosal echogenicity were found related to inflammation or collagen deposition, highlighting fat as the key correlate.

Clinical Implications

Intestinal ultrasound measurement of submucosal echogenicity can serve as a non-invasive biomarker to identify UC patients with submucosal fat deposition who are less likely to respond to anti-inflammatory therapies. This imaging parameter may aid clinicians in stratifying patients and tailoring treatment strategies early in the disease course. Incorporating RSE assessment into routine IUS evaluations could improve prognostication and guide therapeutic decision-making.

Conclusion

Submucosal hyper-echogenicity detected by intestinal ultrasound reflects fat accumulation in the bowel wall and predicts poor response to anti-inflammatory treatment in ulcerative colitis. Quantitative RSE measurement offers a promising tool for personalized management of UC patients.

References

1. van Haaften et al. 2024 -- Intestinal Ultrasound Reveals Submucosal Hyper-Echogenicity Linked to Fat Accumulation and Predicts Lack of Response to Treatment in Ulcerative Colitis Patients